Found: 14
Select item for more details and to access through your institution.
PARP inhibition in ovarian cancer: what is still missing?
- Published in:
- European Journal of Gynaecological Oncology, 2022, v. 43, n. 1, p. 143, doi. 10.31083/j.ejgo4301016
- By:
- Publication type:
- Article
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 2, p. 442, doi. 10.3390/cells9020442
- By:
- Publication type:
- Article
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4414, doi. 10.3390/ijms21124414
- By:
- Publication type:
- Article
Ovarian Cancer Immunotherapy: Turning up the Heat.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 12, p. 2927, doi. 10.3390/ijms20122927
- By:
- Publication type:
- Article
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2353, doi. 10.3390/ijms20092353
- By:
- Publication type:
- Article
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
- Published in:
- Journal of Ovarian Research, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13048-019-0492-6
- By:
- Publication type:
- Article
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.
- Published in:
- Journal of Ovarian Research, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13048-018-0415-y
- By:
- Publication type:
- Article
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
- Published in:
- Journal of Ovarian Research, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13048-020-00655-2
- By:
- Publication type:
- Article
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+ </sup>T-myeloid cell networks in melanoma.
- Published in:
- Science Immunology, 2024, v. 9, n. 92, p. 1, doi. 10.1126/sciimmunol.adg7995
- By:
- Publication type:
- Article
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3639, doi. 10.3390/cancers15143639
- By:
- Publication type:
- Article
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1032, doi. 10.3390/cancers15041032
- By:
- Publication type:
- Article
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2239, doi. 10.3390/cancers12082239
- By:
- Publication type:
- Article
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1820, doi. 10.3390/cancers11111820
- By:
- Publication type:
- Article
Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 5, p. 481, doi. 10.1159/000502538
- By:
- Publication type:
- Article